Does Dr. ANABEL ALCARAZ VARGAS have financial conflicts of interest?

Dr. ANABEL ALCARAZ VARGAS (MD, MPH) has received a total of $46 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $46 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ANABEL ALCARAZ VARGAS?

According to CMS Open Payments data, Dr. ANABEL ALCARAZ VARGAS received funding from ALKERMES ($26) and MERCK SHARP & DOHME ($20).

Does Dr. ANABEL ALCARAZ VARGAS receive research grants or speaking fees?

Dr. ANABEL ALCARAZ VARGAS has received $46 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ANABEL ALCARAZ VARGAS

MD, MPHReal-Time Hydrated

Specialty: Student in an Organized Health Care Education/Training Program

Practice Location: MISSION HILLS, CA 91345

NPI Number: 1730821497

LIFETIME INDUSTRY VALUE

$46

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALCARAZ VARGAS is a verified Student in an Organized Health Care Education/Training Program practitioner based in MISSION HILLS, CA.

Between 2021 and 2025, Dr. ALCARAZ VARGAS had an overall industry promotional and research financial footprint of $46 as recorded in the federal CMS Open Payments database.

$46 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALCARAZ VARGAS's primary funding source is ALKERMES, which accounts for $26 (representing 56.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ALKERMES

Rank 1

$26

56.4%

MERCK SHARP & DOHME

Rank 2

$20

43.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.